BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12082018)

  • 1. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.
    Karan D; Kelly DL; Rizzino A; Lin MF; Batra SK
    Carcinogenesis; 2002 Jun; 23(6):967-75. PubMed ID: 12082018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
    Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
    Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
    Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
    Rice L; Handayani R; Cui Y; Medrano T; Samedi V; Baker H; Szabo NJ; Rosser CJ; Goodison S; Shiverick KT
    J Nutr; 2007 Apr; 137(4):964-72. PubMed ID: 17374662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
    Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
    Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
    Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated expression of MIC-1/PDF in human prostate tumor cells.
    Karan D; Chen SJ; Johansson SL; Singh AP; Paralkar VM; Lin MF; Batra SK
    Biochem Biophys Res Commun; 2003 Jun; 305(3):598-604. PubMed ID: 12763036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
    Chang GT; Blok LJ; Steenbeek M; Veldscholte J; van Weerden WM; van Steenbrugge GJ; Brinkmann AO
    Cancer Res; 1997 Sep; 57(18):4075-81. PubMed ID: 9307296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
    Kokontis J; Takakura K; Hay N; Liao S
    Cancer Res; 1994 Mar; 54(6):1566-73. PubMed ID: 7511045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.
    Pang ST; Weng WH; Flores-Morales A; Johansson B; Pourian MR; Nilsson P; Pousette A; Larsson C; Norstedt G
    Prostate; 2006 Feb; 66(2):157-72. PubMed ID: 16173030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
    Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
    Lu S; Tsai SY; Tsai MJ
    Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of novel androgen-regulated genes in prostate cancer.
    Velasco AM; Gillis KA; Li Y; Brown EL; Sadler TM; Achilleos M; Greenberger LM; Frost P; Bai W; Zhang Y
    Endocrinology; 2004 Aug; 145(8):3913-24. PubMed ID: 15131019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.
    Kojima S; Mulholland DJ; Ettinger S; Fazli L; Nelson CC; Gleave ME
    Prostate; 2006 Jun; 66(9):971-86. PubMed ID: 16541420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.